Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 455K 422K 388K 734K 49.67M 748K 5.02M 1.97M 24.39M 1.95M 1.91M 84.24M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.34M 17.91M 16.48M 31.17M 2.11B 31.78M 213M 83.73M 1.04B 82.79M 80.98M 3.58B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

Nov. 18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-31	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-14	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-04	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
23-10-01	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
23-09-29	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
23-08-15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-01	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
23-06-15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

Nov. 18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
24-05-16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
24-05-16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
23-10-05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
23-10-02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.20%	-0.88%	+48.80%	+173.63%	1,060B
JOHNSON & JOHNSON	+0.33%	-0.26%	+64.93%	+62.87%	619B
ABBVIE INC.	+0.00%	-2.77%	+29.33%	+85.41%	438B
ROCHE HOLDING AG	-1.75%	-0.33%	+28.33%	+23.58%	333B
NOVARTIS AG	+0.24%	-0.42%	+29.19%	+47.26%	282B
ASTRAZENECA PLC	-1.75%	-10.57%	+18.27%	+22.07%	267B
NOVO NORDISK A/S	+0.67%	+1.03%	-26.81%	-37.96%	218B
AMGEN INC.	-0.82%	-1.54%	+21.46%	+58.47%	196B
GILEAD SCIENCES, INC.	+1.23%	+1.42%	+17.28%	+71.37%	161B
Average	-0.14%	-3.33%	+25.64%	+56.30%	397.1B
Weighted average by Cap.	-0.14%	-3.10%	+35.94%	+84.53%

Exactus Inc Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

	2022	2023
Net sales	1.63M 1.43M 1.32M 1.22M 2.3M 156M 2.34M 15.75M 6.18M 76.47M 6.11M 5.98M 264M	2.38M 2.09M 1.94M 1.78M 3.37M 228M 3.44M 23.09M 9.06M 112M 8.96M 8.76M 387M
Net income	-9.14M -8.02M -7.43M -6.83M -12.93M -875M -13.18M -88.52M -34.72M -430M -34.33M -33.58M -1.48B	-8.02M -7.03M -6.51M -5.99M -11.33M -767M -11.55M -77.61M -30.44M -377M -30.1M -29.44M -1.3B
Net Debt	17.85M 15.66M 14.5M 13.34M 25.24M 1.71B 25.73M 173M 67.8M 839M 67.04M 65.58M 2.9B	21.53M 18.88M 17.49M 16.09M 30.44M 2.06B 31.03M 208M 81.76M 1.01B 80.85M 79.08M 3.49B